The company currently has multiple innovative drug research projects and dozens of patents, including PCT international invention patents, US and EU invention patents, Chinese invention patents, utility model and appearance patents, etc. Since its establishment, the company has undertaken more than 40 scientific research projects, including the National 12th and 13th Five Year Plan "Major New Drug Creation" Science and Technology Key Special Projects, and the National "Outstanding Funding for Science and Technology Innovation and Entrepreneurship Projects for Returned Students".
Nanjing Denovo Pharmaceutical Technology Co., Ltd.
Since its establishment in May 2020, the company has been mainly engaged in the preclinical research and development of first-in-class anti-infection and anti-tumor peptide drugs and chemical drugs.The company currently has a strong R&D team mainly composed of doctors and masters, with advanced experimental conditions and equipment.
Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd.
Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd. was established in 2006. It is mainly engaged in the preclinical research of peptide drugs and chemical drugs as well as the research and development of innovative disinfection products.